Anti-VEGF injections are a common treatment for wet age-related macular degeneration (AMD), aimed at preserving or even improving vision by stopping abnormal blood vessel growth under the macula. These injections block vascular endothelial growth factor (VEGF), which drives leakage and swelling in the retina. Though not a cure, this therapy can slow or halt vision loss in many patients. The procedure involves numbing the eye and injecting the medication into the vitreous. Risks include inflammation, floaters, infection, and in rare cases, serious complications like stroke. Staying on schedule with appointments and reporting vision changes immediately is crucial.